Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 380

1.

Long-term efficacy and safety of phrenic nerve stimulation for the treatment of central sleep apnea.

Fox H, Oldenburg O, Javaheri S, Ponikowski P, Augostini R, Goldberg LR, Stellbrink C, Mckane S, Meyer TE, Abraham WT, Costanzo MR.

Sleep. 2019 Oct 21;42(11). pii: zsz158. doi: 10.1093/sleep/zsz158.

2.

When Technology Exceeds its Application: The First Reported Reconstruction of the Iliocaval Confluence Using an Aortic Endograft.

Harmon TS, Villescas VV, Hood P, Meyer TE, Matteo J.

Cureus. 2019 May 10;11(5):e4640. doi: 10.7759/cureus.4640.

3.

Nail Gun Injury and Endovascular Repair of Cervical Internal Carotid Artery.

Brzezicki G, Meyer TE, Madbak F, Widrich J, Jensen A.

Cureus. 2019 Mar 12;11(3):e4237. doi: 10.7759/cureus.4237.

4.

Complicated Complication: How Interventional Radiologists Should Manage Acute Iatrogenic Cardiac Tamponade.

Harmon TS, Wynn G, Meyer TE, Siragusa D, Matteo J.

Cureus. 2018 Dec 8;10(12):e3708. doi: 10.7759/cureus.3708.

5.

Days' Supply of Initial Opioid Analgesic Prescriptions and Additional Fills for Acute Pain Conditions Treated in the Primary Care Setting - United States, 2014.

Mundkur ML, Franklin JM, Abdia Y, Huybrechts KF, Patorno E, Gagne JJ, Meyer TE, Staffa J, Bateman BT.

MMWR Morb Mortal Wkly Rep. 2019 Feb 15;68(6):140-143. doi: 10.15585/mmwr.mm6806a3.

6.

Pre-cryoablation Embolization of Renal Tumors: Decreasing Probes and Saving Loads.

Harmon TS, Matteo J, Meyer TE, Kee-Sampson J.

Cureus. 2018 Dec 3;10(12):e3676. doi: 10.7759/cureus.3676.

7.

Hydro-marking Your Territory: Using a Novel Percutaneous Tagging System to Assist Pulmonary Nodule Identification During Video-assisted Thoracoscopic Surgery.

Harmon TS, Siragusa D, Cunningham J, Meyer TE, Kee-Sampson J, Matteo J.

Cureus. 2018 Nov 12;10(11):e3572. doi: 10.7759/cureus.3572.

8.

Patterns of Immediate-Release and Extended-Release Opioid Analgesic Use in the Management of Chronic Pain, 2003-2014.

Hwang CS, Kang EM, Ding Y, Ocran-Appiah J, McAninch JK, Staffa JA, Kornegay CJ, Meyer TE.

JAMA Netw Open. 2018 Jun 1;1(2):e180216. doi: 10.1001/jamanetworkopen.2018.0216.

9.

Draft Genome Sequence and Brief History of Rhodovulum sp. Strain BSW8.

Rayyan AA, Meyer TE, Kyndt JA.

Microbiol Resour Announc. 2018 Aug 23;7(7). pii: e00983-18. doi: 10.1128/MRA.00983-18. eCollection 2018 Aug.

10.

Solving the Chinese Finger Trap: A Novel Method for Simultaneous Superior and Inferior Vena Cava Filter Removal.

Harmon TS, Agrait M, Sifrig B, Matteo J, Meyer TE.

Cureus. 2018 Oct 2;10(10):e3400. doi: 10.7759/cureus.3400.

11.

You Can Do That? Performing Total Recanalization of Completely Stented Arterial-venous Grafts.

Harmon TS, Meyer TE, Matteo J.

Cureus. 2018 Oct 1;10(10):e3396. doi: 10.7759/cureus.3396.

12.

Development of a biomarker panel to predict cardiac resynchronization therapy response: Results from the SMART-AV trial.

Spinale FG, Meyer TE, Stolen CM, Van Eyk JE, Gold MR, Mittal S, DeSantis SM, Wold N, Beshai JF, Stein KM, Ellenbogen KA; SMART-AV Trial Investigators.

Heart Rhythm. 2019 May;16(5):743-753. doi: 10.1016/j.hrthm.2018.11.026. Epub 2018 Nov 24.

PMID:
30476543
13.

Effect of Interventricular Electrical Delay on Atrioventricular Optimization for Cardiac Resynchronization Therapy.

Gold MR, Yu Y, Singh JP, Birgersdotter-Green U, Stein KM, Wold N, Meyer TE, Ellenbogen KA.

Circ Arrhythm Electrophysiol. 2018 Aug;11(8):e006055. doi: 10.1161/CIRCEP.117.006055.

14.

Secondary mitral regurgitation (part 2): deliberations on mitral surgery and transcatheter repair.

Gaasch WH, Meyer TE.

Heart. 2018 Apr;104(8):639-643. doi: 10.1136/heartjnl-2017-312002. Epub 2018 Feb 2. Review.

PMID:
29437886
15.

Secondary mitral regurgitation (part 1): volumetric quantification and analysis.

Gaasch WH, Meyer TE.

Heart. 2018 Apr;104(8):634-638. doi: 10.1136/heartjnl-2017-312001. Epub 2017 Sep 27. Review.

PMID:
28954829
16.

Bioimpedance-Based Heart Failure Deterioration Prediction Using a Prototype Fluid Accumulation Vest-Mobile Phone Dyad: An Observational Study.

Darling CE, Dovancescu S, Saczynski JS, Riistama J, Sert Kuniyoshi F, Rock J, Meyer TE, McManus DD.

JMIR Cardio. 2017 Mar 13;1(1):e1. doi: 10.2196/cardio.6057.

17.

The burden of proof: The current state of atrial fibrillation prevention and treatment trials.

Zakeri R, Van Wagoner DR, Calkins H, Wong T, Ross HM, Heist EK, Meyer TE, Kowey PR, Mentz RJ, Cleland JG, Pitt B, Zannad F, Linde C.

Heart Rhythm. 2017 May;14(5):763-782. doi: 10.1016/j.hrthm.2017.01.032. Epub 2017 Feb 2. Review.

18.
19.

Soluble ST2 and Risk of Arrhythmias, Heart Failure, or Death in Patients with Mildly Symptomatic Heart Failure: Results from MADIT-CRT.

Skali H, Gerwien R, Meyer TE, Snider JV, Solomon SD, Stolen CM.

J Cardiovasc Transl Res. 2016 Dec;9(5-6):421-428. Epub 2016 Oct 31.

PMID:
27798759
20.

Impedance to retrograde and forward flow in chronic mitral regurgitation and the physiology of a double outlet ventricle.

Gaasch WH, Shah SP, Labib SB, Meyer TE.

Heart. 2017 Apr;103(8):581-585. doi: 10.1136/heartjnl-2016-309747. Epub 2016 Sep 28.

PMID:
27683406
21.

Interventricular Electrical Delay Is Predictive of Response to Cardiac Resynchronization Therapy.

Gold MR, Singh JP, Ellenbogen KA, Yu Y, Wold N, Meyer TE, Birgersdoter-Green U.

JACC Clin Electrophysiol. 2016 Aug;2(4):438-447. doi: 10.1016/j.jacep.2016.02.018. Epub 2016 May 18.

22.

Current Trends In Medical Education: What Does Our Future Hold?

Phelan D, George A, Meyer TE.

Md Med. 2016;17(1):23-4. No abstract available.

PMID:
27443126
23.

Successful Comparison of US Food and Drug Administration Sentinel Analysis Tools to Traditional Approaches in Quantifying a Known Drug-Adverse Event Association.

Gagne JJ, Han X, Hennessy S, Leonard CE, Chrischilles EA, Carnahan RM, Wang SV, Fuller C, Iyer A, Katcoff H, Woodworth TS, Archdeacon P, Meyer TE, Schneeweiss S, Toh S.

Clin Pharmacol Ther. 2016 Nov;100(5):558-564. doi: 10.1002/cpt.429. Epub 2016 Aug 22.

24.

Mitoxantrone-Induced Cardiotoxicity in Acute Myeloid Leukemia-A Velocity Vector Imaging Analysis.

Shaikh AY, Suryadevara S, Tripathi A, Ahmed M, Kane JL, Escobar J, Cerny J, Nath R, McManus DD, Shih J, McGuiness ME, Tighe DA, Meyer TE, Ramanathan M, Aurigemma GP.

Echocardiography. 2016 Aug;33(8):1166-77. doi: 10.1111/echo.13245. Epub 2016 Apr 24.

PMID:
27109429
25.

Risk of heart failure with dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.

Kundu A, Sardar P, Ghosh S, Patel P, Chatterjee S, Meyer TE.

Int J Cardiol. 2016 Jun 1;212:203-5. doi: 10.1016/j.ijcard.2016.03.016. Epub 2016 Mar 19. No abstract available.

PMID:
27043061
26.

Novel measure of electrical dyssynchrony predicts response in cardiac resynchronization therapy: Results from the SMART-AV Trial.

Tereshchenko LG, Cheng A, Park J, Wold N, Meyer TE, Gold MR, Mittal S, Singh J, Stein KM, Ellenbogen KA; SMART-AV Trial Investigators.

Heart Rhythm. 2015 Dec;12(12):2402-10. doi: 10.1016/j.hrthm.2015.08.009. Epub 2015 Aug 10.

27.

Creating and Maintaining a Successful Service Line in an Academic Medical Center at the Dawn of Value-Based Care: Lessons Learned From the Heart and Vascular Service Line at UMass Memorial Health Care.

Phillips RA, Cyr J, Keaney JF Jr, Messina LM, Meyer TE, Tam SK, Korenda K, Darrigo M, Kumar P, Challapalli S.

Acad Med. 2015 Oct;90(10):1340-6. doi: 10.1097/ACM.0000000000000839.

PMID:
26222322
28.

Non-steroidal anti-inflammatory drugs use is associated with reduced risk of inflammation-associated cancers: NIH-AARP study.

Shebl FM, Hsing AW, Park Y, Hollenbeck AR, Chu LW, Meyer TE, Koshiol J.

PLoS One. 2014 Dec 31;9(12):e114633. doi: 10.1371/journal.pone.0114633. eCollection 2014.

29.

Cardiorenal syndrome: misgivings about treatment options, clarity on prognosis.

Chung ES, Meyer TE.

J Card Fail. 2015 Feb;21(2):116-8. doi: 10.1016/j.cardfail.2014.11.011. Epub 2014 Dec 3. No abstract available.

PMID:
25481432
30.

Plasma galectin-3 and heart failure outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy).

Stolen CM, Adourian A, Meyer TE, Stein KM, Solomon SD.

J Card Fail. 2014 Nov;20(11):793-9. doi: 10.1016/j.cardfail.2014.07.018. Epub 2014 Aug 6.

31.

Decision-making under uncertainty in advanced heart failure.

Meyer TE, Kiernan MS, McManus DD, Shih J.

Curr Heart Fail Rep. 2014 Jun;11(2):188-96. doi: 10.1007/s11897-014-0195-7. Review.

PMID:
24691659
32.

Usefulness of pancreatitis-associated protein, a novel biomarker, to predict severity of disease in ambulatory patients with heart failure.

Fitzgibbons TP, Paolino J, Dagorn JC, Meyer TE.

Am J Cardiol. 2014 Jan 1;113(1):123-6. doi: 10.1016/j.amjcard.2013.09.026. Epub 2013 Oct 3.

PMID:
24188888
33.

Prospective evaluation of serum sarcosine and risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Koutros S, Meyer TE, Fox SD, Issaq HJ, Veenstra TD, Huang WY, Yu K, Albanes D, Chu LW, Andriole G, Hoover RN, Hsing AW, Berndt SI.

Carcinogenesis. 2013 Oct;34(10):2281-5. doi: 10.1093/carcin/bgt176. Epub 2013 May 22.

34.

The effect of left ventricular electrical delay on AV optimization for cardiac resynchronization therapy.

Gold MR, Yu Y, Singh JP, Stein KM, Birgersdotter-Green U, Meyer TE, Seth M, Ellenbogen KA.

Heart Rhythm. 2013 Jul;10(7):988-93. doi: 10.1016/j.hrthm.2013.03.009. Epub 2013 Mar 14.

PMID:
23499621
35.

Systolic pulmonary and hepatic vein flow reversal due to pacemaker-induced retrograde ventriculoatrial conduction.

Shaikh AY, Meyer TE, Robotis DA, Aurigemma GP, Tighe DA.

Echocardiography. 2013 Mar;30(3):E61-3. doi: 10.1111/echo.12095. Epub 2013 Jan 11.

PMID:
23305160
36.

Alterations in early filling dynamics predict the progression of compensated pressure overload hypertrophy to heart failure better than abnormalities in midwall systolic shortening.

Perlini S, Chung ES, Aurigemma GP, Meyer TE.

Clin Exp Hypertens. 2013;35(6):401-11. doi: 10.3109/10641963.2012.739235. Epub 2012 Nov 7.

PMID:
23134254
37.

Photokinetic, biochemical and structural features of chimeric photoactive yellow protein constructs.

Kyndt JA, Meyer TE, Olson KT, Van Beeumen J, Cusanovich MA.

Photochem Photobiol. 2013 Mar-Apr;89(2):349-60. doi: 10.1111/j.1751-1097.2012.01235.x. Epub 2012 Oct 9.

PMID:
22958002
38.

The growing family of photoactive yellow proteins and their presumed functional roles.

Meyer TE, Kyndt JA, Memmi S, Moser T, Colón-Acevedo B, Devreese B, Van Beeumen JJ.

Photochem Photobiol Sci. 2012 Oct;11(10):1495-514. Review.

PMID:
22911088
39.

Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health System.

Meyer TE, Taylor LG, Xie S, Graham DJ, Mosholder AD, Williams JR, Moeny D, Ouellet-Hellstrom RP, Coster TS.

Addiction. 2013 Jan;108(1):203-10. doi: 10.1111/j.1360-0443.2012.04024.x. Epub 2012 Oct 18.

PMID:
22812921
40.

Caloric restriction may reverse age-related autonomic decline in humans.

Stein PK, Soare A, Meyer TE, Cangemi R, Holloszy JO, Fontana L.

Aging Cell. 2012 Aug;11(4):644-50. doi: 10.1111/j.1474-9726.2012.00825.x. Epub 2012 May 21.

41.

Acetaminophen overdose in the Military Health System.

Taylor LG, Xie S, Meyer TE, Coster TS.

Pharmacoepidemiol Drug Saf. 2012 Apr;21(4):375-83. doi: 10.1002/pds.3206. Epub 2012 Feb 23.

PMID:
22362462
42.

Tyrosine triad at the interface between the Rieske iron-sulfur protein, cytochrome c1 and cytochrome c2 in the bc1 complex of Rhodobacter capsulatus.

Kyndt JA, Fitch JC, Berry RE, Stewart MC, Whitley K, Meyer TE, Walker FA, Cusanovich MA.

Biochim Biophys Acta. 2012 May;1817(5):811-8. doi: 10.1016/j.bbabio.2012.01.013. Epub 2012 Jan 28.

43.

Potential mechanisms underlying the effect of gender on response to cardiac resynchronization therapy: insights from the SMART-AV multicenter trial.

Cheng A, Gold MR, Waggoner AD, Meyer TE, Seth M, Rapkin J, Stein KM, Ellenbogen KA.

Heart Rhythm. 2012 May;9(5):736-41. doi: 10.1016/j.hrthm.2011.12.013. Epub 2011 Dec 17.

PMID:
22182496
44.

Metabolic syndrome and insulin resistance in relation to biliary tract cancer and stone risks: a population-based study in Shanghai, China.

Shebl FM, Andreotti G, Meyer TE, Gao YT, Rashid A, Yu K, Shen MC, Wang BS, Han TQ, Zhang BH, Stanczyk FZ, Hsing AW.

Br J Cancer. 2011 Oct 25;105(9):1424-9. doi: 10.1038/bjc.2011.363. Epub 2011 Sep 13.

45.

The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy.

Gold MR, Birgersdotter-Green U, Singh JP, Ellenbogen KA, Yu Y, Meyer TE, Seth M, Tchou PJ.

Eur Heart J. 2011 Oct;32(20):2516-24. doi: 10.1093/eurheartj/ehr329. Epub 2011 Aug 29.

46.

A reproducible and high-throughput HPLC/MS method to separate sarcosine from α- and β-alanine and to quantify sarcosine in human serum and urine.

Meyer TE, Fox SD, Issaq HJ, Xu X, Chu LW, Veenstra TD, Hsing AW.

Anal Chem. 2011 Jul 15;83(14):5735-40. doi: 10.1021/ac201003r. Epub 2011 Jun 21.

PMID:
21635006
47.

Dietary carbohydrate, glycemic index, glycemic load, and risk of prostate cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort.

Shikany JM, Flood AP, Kitahara CM, Hsing AW, Meyer TE, Willcox BJ, Redden DT, Ziegler RG.

Cancer Causes Control. 2011 Jul;22(7):995-1002. doi: 10.1007/s10552-011-9772-1. Epub 2011 May 7.

48.

The association between inflammation-related genes and serum androgen levels in men: the prostate, lung, colorectal, and ovarian study.

Meyer TE, Chu LW, Li Q, Yu K, Rosenberg PS, Menashe I, Chokkalingam AP, Quraishi SM, Huang WY, Weiss JM, Kaaks R, Hayes RB, Chanock SJ, Hsing AW.

Prostate. 2012 Jan;72(1):65-71. doi: 10.1002/pros.21407. Epub 2011 Apr 25.

49.

Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study.

Saxon LA, Hayes DL, Gilliam FR, Heidenreich PA, Day J, Seth M, Meyer TE, Jones PW, Boehmer JP.

Circulation. 2010 Dec 7;122(23):2359-67. doi: 10.1161/CIRCULATIONAHA.110.960633. Epub 2010 Nov 22.

PMID:
21098452
50.

Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy.

Ellenbogen KA, Gold MR, Meyer TE, Fernndez Lozano I, Mittal S, Waggoner AD, Lemke B, Singh JP, Spinale FG, Van Eyk JE, Whitehill J, Weiner S, Bedi M, Rapkin J, Stein KM.

Circulation. 2010 Dec 21;122(25):2660-8. doi: 10.1161/CIRCULATIONAHA.110.992552. Epub 2010 Nov 15.

PMID:
21098426

Supplemental Content

Loading ...
Support Center